A 77-year-old woman presented with symptomatic thoracic aortic aneurysm within a dissected thoracoabdominal aorta distal to a previous Dacron ascending aortic replacement. She was not a candidate for open repair and had no proximal landing zone for conventional thoracic endovascular aortic repair (TEVAR) resulting from dissection extension into the brachiocephalic vessels. A concomitant parallel graft true and false lumen TEVAR was performed from the distal aortic arch to diaphragm. Follow-up imaging demonstrated successful exclusion of the false lumen aneurysm and successful protection of the true lumen with the adjacent parallel TEVAR device. (J Vasc Surg Cases and Innovative Techniques 2019;5:557-60.) 
Residual chronic DeBakey type I dissection distal to an ascending repair with false lumen (FL) aneurysmal degeneration would classically be treated with open arch reconstruction or left chest open thoracic repair, depending on the site of the aneurysm and the diameter of the arch. This presents significant therapeutic challenges when open surgery is contraindicated because of the physiologic impact of the operation. Total endovascular arch repair has had promising results, but device unavailability, technical complexity, and patient anatomy limit its utility in common practice. Also, dissection into the brachiocephalic vessels, short/angulated proximal Dacron, mechanical heart valves, and existing coronary bypass artery grafts arising from the ascending aorta can preclude or further complicate this type of repair. We present a case in which concomitant true lumen (TL) and FL thoracic endovascular aortic repair (TEVAR) was performed to treat a patient with a large symptomatic FL aneurysm in a residual type I dissection, providing exclusion of the aneurysm without manipulation of the dissected proximal aortic arch. The patient authorized the disclosure of her case details and images.
CASE REPORT
A 77-year-old female with emphysema, coronary artery disease, chronic kidney disease (creatinine 2.9), and a history of ascending aortic repair for acute dissection 13 years prior with a subsequent coronary bypass artery graft arising from her Dacron repair 1 year after that procedure now presents with rapid enlargement (6.5-7.8 cm) of her known thoracic aortic aneurysm and mid-back and left flank pain. 
DISCUSSION
An isolated hemiarch replacement to the level of the innominate artery remains the most common operation performed for acute type A dissection. This limited replacement specifically in DeBakey type I pathology can leave residual dissection within and distal to the arch. FL patency is an independent risk factor for rate of distal aortic enlargement 1,2 and a predictor of late death and need for distal reintervention, 3 often because of aneurysm. 4 Following type I repair, reoperation rates are reported to be 21% to 39% at 10 years 1,4-6 and residual dissection has been noted in 64% to 90% of patients. 1, 3, 6, 7 An estimated 12% of reoperations are due to aneurysm of the arch, requiring open reconstruction. 4 Even at highvolume aortic centers, these operations carry significant morbidity risk and a 1-year mortality risk of 10%. 8 Endovascular dissection repair traditionally aims to eliminate FL flow through occlusion of the dominant septal tear with resulting depressurization of the FL. Because of dissection involvement of the aortic arch with the arch branches supplied by FL flow, historically the only solutions for this patient would have been total arch, hybrid arch, or open left chest thoracic aortic reconstruction. Eliminating the necessity for complex arch reconstruction, parallel TEVAR within the TL/FL allows continued flow through both lumens, providing protection from TL compression and sealing above and below the FL aneurysm to alleviate aneurysmal FL wall stress, while preserving flow to the arch branches and any visceral/renal vessels arising from the FL distally. Although data on the long-term efficacy of this approach are lacking, previous reports have supported the safety of endovascular false lumen manipulation and stenting. 9, 10 This technique specifically applies to treatment of residual dissection after previous type I repair and should be applied only to select patients with a nonaneurysmal proximal and distal descending thoracic aorta to provide landing zones for the parallel TEVAR grafts. There are no strict sizing criteria, but endograft sizing should allow graft expansion in both lumens and seal within their respective lumens. This patient had a total aortic diameter of 40 mm proximally and 36 mm distally, with TL and FL of equivalent sizes. Here, we achieved good results with 28-mm grafts in each lumen.
Given the often-complex flow dynamics associated with a dissection such as this, consideration should be given to the perfusion of any vessels arising from the TL and FL once the devices are deployed. In this patient, because the primary flow into the dissection was within the arch and the brachiocephalic vessels were perfused from both the TL and FL, we felt that there was no risk of malperfusion after concomitant graft deployment. An alternative strategy could be argued to expand the TL, but given the dissection up into the brachiocephalic vessels, there would be unclear consequences regarding cerebral perfusion, along with sacrifice of the celiac artery, which may also lead to complications avoidable with parallel TEVAR. We believe that follow-up after this procedure should be conducted as would be for any chronic dissection patient treated with an endovascular approach for aneurysmal degeneration. In our practice, we typically perform a 1-month, 6-month, and yearly CT angiograph after repair.
CONCLUSIONS
In dissection involving the aortic arch, parallel TL/FL TEVAR may provide an effective alternative in select patients. Although open reconstruction remains the mainstay of therapy, we propose a minimally invasive solution for patients with contraindications to open repair.
